Cis- and trans-cleavage activity of CRISPR-Cas9 and its new developments in diagnostics
CRISPR-Cas system is an adaptive immune system of prokaryotes against foreign invading viruses. Type II CRISPR-Cas9 system, as the earliest of the Class II systems to be discovered and applied to gene editing, had its new discovery of sharing trans-cleavage activity with other Class II systems not long ago. In this review, we summarize the molecular mechanism of cis- and trans-cleavage of target nucleic acids by the Class II type II CRISPR-Cas system, introduce the nucleic acid detection platforms developed based on its trans-cleavage activity, and compare them with those developed based on the type V, type VI, and type I CRISPR-Cas systems.
Authors
- Liang Liu (ORCID: https://orcid.org/0000-0002-7073-0717)
- Linglong Huang (ORCID: https://orcid.org/0009-0006-9971-7774)
- Jiyun Chen (ORCID: https://orcid.org/0000-0002-9423-0258)
- Xueying Li (ORCID: https://orcid.org/0000-0003-1984-3609)
- Ying Chen (ORCID: https://orcid.org/0000-0003-1960-419X)
Institutions
- Xiamen University (CN)
Publication Details
- Journal
- Health and Metabolism
- Published
- 2025-07-16
- DOI
- https://doi.org/10.53941/hm.2025.100021
- Citations
- 1
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.81